Aaron A. King, MD (he/him/his)

PHysician
MedFirst at the Quarry

Poster(s):

• (P116) Real-World Effectiveness of Once-Weekly Semaglutide in Glycemic Control and Weight Outcomes in Type 2 Diabetes
  Saturday, August 5, 2023

  11:00 AM – 1:00 PM CT

• (P117) Real-World Effectiveness of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists (OW GLP-1 RAs) on Glycemic Control and Weight Outcomes in Type 2 Diabetes
  Saturday, August 5, 2023

  11:00 AM – 1:00 PM CT

• (P118) REal-World Impact of Once-Weekly Injectable Semaglutide on GLycemic Control and Weight Outcomes Based on Highest Dose Received and Persistence With Treatment in Type 2 DiAbeTEs (RELATE – OW Injectable Semaglutide)
  Saturday, August 5, 2023

  11:00 AM – 1:00 PM CT

• (P119) REal-World Impact of Oral Semaglutide on GLycemic Control and Weight Outcomes Based on Highest Dose Received and Persistence With Treatment in Type 2 DiAbeTEs (RELATE – Oral Semaglutide)
  Saturday, August 5, 2023

  11:00 AM – 1:00 PM CT